Cytotoxic pharmaceutical composition

Details Cytotoxic pharmaceutical composition Cytotoxic pharmaceutical composition

2001-11-27

2003-04-08

Lankford, Jr., Leon B. (Department: 1651)

Drug, bio-affecting and body treating compositions

Plant material or plant extract of undetermined constitution...

Containing or obtained from camellia

C424S451000, C424S195150, C424S756000, C514S002600

Reexamination Certificate

active

06544564

ABSTRACT:

This invention relates to an immunity system of a human body, against viral and infectious disease and cancer.
The immune function is a system that functions to include absorption of excess fluid and its return to the blood stream, absorption of fat and finally to the immune system function.
Immunity is the body's capability to repel foreign substances and cells. The non specific responses are the first line of defense. Highly specific responses are the second line of defenses and are tailored to an individual threat.


REFERENCES:
patent: 5416070 (1995-05-01), Vosika et al.
patent: 5824648 (1998-10-01), Yang et al.
patent: 5904924 (1999-05-01), Gaynor et al.
patent: 5910308 (1999-06-01), D'Jang
patent: 5935581 (1999-08-01), Kapadia et al.
patent: 5948808 (1999-09-01), Safe
patent: 6008260 (1999-12-01), Pezzuto et al.
Choi et al. Anticancer Research (1999), vol. 19, pp. 5229-5233.*
Ong et al. Gen. Pharmacol. (1997), vol. 29, No. 2, pp. 121-126.

Affiliated with

Also associated with

Rating

Cytotoxic pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cytotoxic pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytotoxic pharmaceutical composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3088881